Journal Article
A. - M. Lacosta, Insua, D., Badi, H., Pesini, P., and Sarasa, M.,
“Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.”,
J Alzheimers Dis, vol. 58, no. 3, pp. 661-667, 2017.
T. Matsuoka, Imai, A., Fujimoto, H., Kato, Y., Shibata, K., Nakamura, K., Yokota, H., Yamada, K., and Narumoto, J.,
“Neural Correlates of Sleep Disturbance in Alzheimer's Disease: Role of the Precuneus in Sleep Disturbance.”,
J Alzheimers Dis, vol. 63, no. 3, pp. 957-964, 2018.
H. Kazui, Takahashi, R., Yamamoto, Y., Yoshiyama, K., Kanemoto, H., Suzuki, Y., Sato, S., Azuma, S., Suehiro, T., Shimosegawa, E., Ishii, K., and Tanaka, T.,
“Neural Basis of Apathy in Patients with Amnestic Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 55, no. 4, pp. 1403-1416, 2017.
G. L. Iverson, C Keene, D., Perry, G., and Castellani, R. J.,
“The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features.”,
J Alzheimers Dis, vol. 61, no. 1, pp. 17-28, 2018.
P. R. Asih, Tegg, M. L., Sohrabi, H., Carruthers, M., Gandy, S. E., Saad, F., Verdile, G., Ittner, L. M., and Martins, R. N.,
“Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer's Disease: Testosterone as a Modifier.”,
J Alzheimers Dis, vol. 59, no. 2, pp. 445-466, 2017.
W. Khan, Giampietro, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., Flor, H., Frouin, V., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Lemaître, H., Nees, F., Paus, T., Pausova, Z., Rietschel, M., Smolka, M. N., Ströhle, A., Gallinat, J., Vellas, B., Soininen, H., Kloszewska, I., Tsolaki, M., Mecocci, P., Spenger, C., Villemagne, V. L., Masters, C. L., Muehlboeck, J. - S., Bäckman, L., Fratiglioni, L., Kalpouzos, G., Wahlund, L. - O., Schumann, G., Lovestone, S., Williams, S. C. R., Westman, E., and Simmons, A.,
“A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
W. Khan, Giampietro, V., Banaschewski, T., Barker, G. J., Bokde, A. L. W., Büchel, C., Conrod, P., Flor, H., Frouin, V., Garavan, H., Gowland, P., Heinz, A., Ittermann, B., Lemaître, H., Nees, F., Paus, T., Pausova, Z., Rietschel, M., Smolka, M. N., Ströhle, A., Gallinat, J., Vellas, B., Soininen, H., Kloszewska, I., Tsolaki, M., Mecocci, P., Spenger, C., Villemagne, V. L., Masters, C. L., Muehlboeck, J. - S., Bäckman, L., Fratiglioni, L., Kalpouzos, G., Wahlund, L. - O., Schumann, G., Lovestone, S., Williams, S. C. R., Westman, E., and Simmons, A.,
“A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 3, pp. 1159-1174, 2017.
H. - K. Lee, Kwon, B., Lemere, C. A., de la Monte, S., Itamura, K., Ha, A. Y., and Querfurth, H. W.,
“mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.”,
J Alzheimers Dis, vol. 56, no. 3, pp. 1015-1036, 2017.
S. Baez, Trujillo-Llano, C., de Souza, L. Cruz, Lillo, P., Forno, G., Santamaría-García, H., Okuma, C., Alegria, P., Huepe, D., Ibáñez, A., Decety, J., and Slachevsky, A.,
“Moral Emotions and Their Brain Structural Correlates Across Neurodegenerative Disorders.”,
J Alzheimers Dis, vol. 92, no. 1, pp. 153-169, 2023.
S. J. B. Vos, van Boxtel, M. P. J., Schiepers, O. J. G., Deckers, K., de Vugt, M., Carrière, I., Dartigues, J. - F., Pérès, K., Artero, S., Ritchie, K., Galluzzo, L., Scafato, E., Frisoni, G. B., Huisman, M., Comijs, H. C., Sacuiu, S. F., Skoog, I., Irving, K., O'Donnell, C. A., Verhey, F. R. J., Visser, P. Jelle, and Köhler, S.,
“Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.”,
J Alzheimers Dis, vol. 58, no. 2, pp. 537-547, 2017.
K. K. Indorewalla, O'Connor, M. K., Budson, A. E., DiTerlizzi, C. Guess, and Jackson, J.,
“Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer's Disease Research.”,
J Alzheimers Dis, vol. 80, no. 3, pp. 927-940, 2021.
T. Kondo, Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., Takahashi, K., Asaka, I., Aoi, T., Watanabe, A., Watanabe, K., Kadoya, C., Nakano, R., Watanabe, D., Maruyama, K., Hori, O., Hibino, S., Choshi, T., Nakahata, T., Hioki, H., Kaneko, T., Naitoh, M., Yoshikawa, K., Yamawaki, S., Suzuki, S., Hata, R., Ueno, S. - I., Seki, T., Kobayashi, K., Toda, T., Murakami, K., Irie, K., Klein, W. L., Mori, H., Asada, T., Takahashi, R., Iwata, N., Yamanaka, S., and Inoue, H.,
“Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.”,
Cell Stem Cell, vol. 12, no. 4, pp. 487-96, 2013.
T. Kondo, Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., Takahashi, K., Asaka, I., Aoi, T., Watanabe, A., Watanabe, K., Kadoya, C., Nakano, R., Watanabe, D., Maruyama, K., Hori, O., Hibino, S., Choshi, T., Nakahata, T., Hioki, H., Kaneko, T., Naitoh, M., Yoshikawa, K., Yamawaki, S., Suzuki, S., Hata, R., Ueno, S. - I., Seki, T., Kobayashi, K., Toda, T., Murakami, K., Irie, K., Klein, W. L., Mori, H., Asada, T., Takahashi, R., Iwata, N., Yamanaka, S., and Inoue, H.,
“Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.”,
Cell Stem Cell, vol. 12, no. 4, pp. 487-96, 2013.
T. Kondo, Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., Takahashi, K., Asaka, I., Aoi, T., Watanabe, A., Watanabe, K., Kadoya, C., Nakano, R., Watanabe, D., Maruyama, K., Hori, O., Hibino, S., Choshi, T., Nakahata, T., Hioki, H., Kaneko, T., Naitoh, M., Yoshikawa, K., Yamawaki, S., Suzuki, S., Hata, R., Ueno, S. - I., Seki, T., Kobayashi, K., Toda, T., Murakami, K., Irie, K., Klein, W. L., Mori, H., Asada, T., Takahashi, R., Iwata, N., Yamanaka, S., and Inoue, H.,
“Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.”,
Cell Stem Cell, vol. 12, no. 4, pp. 487-96, 2013.
T. Kondo, Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., Takahashi, K., Asaka, I., Aoi, T., Watanabe, A., Watanabe, K., Kadoya, C., Nakano, R., Watanabe, D., Maruyama, K., Hori, O., Hibino, S., Choshi, T., Nakahata, T., Hioki, H., Kaneko, T., Naitoh, M., Yoshikawa, K., Yamawaki, S., Suzuki, S., Hata, R., Ueno, S. - I., Seki, T., Kobayashi, K., Toda, T., Murakami, K., Irie, K., Klein, W. L., Mori, H., Asada, T., Takahashi, R., Iwata, N., Yamanaka, S., and Inoue, H.,
“Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.”,
Cell Stem Cell, vol. 12, no. 4, pp. 487-96, 2013.
E. Idrizbegovic, Hederstierna, C., and Rosenhall, U.,
“Mismatch Negativity and Ear Laterality in Alzheimer's Disease and in Mild Cognitive Impairment.”,
J Alzheimers Dis, vol. 53, no. 4, pp. 1405-10, 2016.
D. J. Quintana-Hernández, Miró-Barrachina, M. T., Ibáñez-Fernández, I. J., Del Pino, A. Santana-, Quintana-Montesdeoca, M. P., de Vera, B. Rodríguez, Morales-Casanova, D., Pérez-Vieitez, M. Del Carmen, Rodríguez-García, J., and Bravo-Caraduje, N.,
“Mindfulness in the Maintenance of Cognitive Capacities in Alzheimer's Disease: A Randomized Clinical Trial.”,
J Alzheimers Dis, vol. 50, no. 1, pp. 217-32, 2016.
Z. Ismail, Agüera-Ortiz, L., Brodaty, H., Cieslak, A., Cummings, J., Fischer, C. E., Gauthier, S., Geda, Y. E., Herrmann, N., Kanji, J., Lanctôt, K. L., Miller, D. S., Mortby, M. E., Onyike, C. U., Rosenberg, P. B., Smith, E. E., Smith, G. S., Sultzer, D. L., and Lyketsos, C.,
“The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations.”,
J Alzheimers Dis, vol. 56, no. 3, pp. 929-938, 2017.
Z. Ismail, McGirr, A., Gill, S., Hu, S., Forkert, N. D., and Smith, E. E.,
“Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline.”,
J Alzheimers Dis, vol. 80, no. 1, pp. 459-469, 2021.
P. Iso-Markku, Waller, K., Vuoksimaa, E., Heikkilä, K., Rinne, J., Kaprio, J., and Kujala, U. M.,
“Midlife Physical Activity and Cognition Later in Life: A Prospective Twin Study.”,
J Alzheimers Dis, vol. 54, no. 4, pp. 1303-1317, 2016.
R. Tortelli, Lozupone, M., Guerra, V., Barulli, M. Rosaria, Imbimbo, B. P., Capozzo, R., Grasso, A., Tursi, M., Di Dio, C., Sardone, R., Giannelli, G., Seripa, D., Misciagna, G., Panza, F., and Logroscino, G.,
“Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline.”,
J Alzheimers Dis, vol. 59, no. 1, pp. 121-130, 2017.
N. Sahara, Maeda, J., Ishikawa, A., Tokunaga, M., Suhara, T., and Higuchi, M.,
“Microglial Activation During Pathogenesis of Tauopathy in rTg4510 Mice: Implications for the Early Diagnosis of Tauopathy.”,
J Alzheimers Dis, vol. 64, no. s1, pp. S353-S359, 2018.
J. A. Luchsinger, Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., and Bagiella, E.,
“Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.”,
J Alzheimers Dis, vol. 51, no. 2, pp. 501-14, 2016.
S. Nasoohi, Parveen, K., and Ishrat, T.,
“Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers.”,
J Alzheimers Dis, vol. 66, no. 3, pp. 857-885, 2018.
T. Kishi, Matsunaga, S., and Iwata, N.,
“A Meta-Analysis of Memantine for Depression.”,
J Alzheimers Dis, vol. 57, no. 1, pp. 113-121, 2017.
] Year 